Biochemical and biophysical research communicationsBiflavonoidsProanthocyanidinsHumansOvarian NeoplasmsFemale
Integrated network pharmacology and experimental models uncover the mechanism of procyanidin B2 against ovarian carcinoma via EGFR/AKT pathway.
Tianyu Zhou, Qihua Sun, Chen Su, Jiali Ling, Shuo Wang, Peng Chu, Xingping Duan
Published: 202610.1016/j.bbrc.2025.153108
Abstract
Ovarian carcinoma (OC) remains a lethal malignancy with limited therapeutic options. Procyanidin B2, a natural flavonoid, has demonstrated broad bioactivity, yet its potential role in ovarian cancer remains incompletely understood. This study employe…
Preview only. Read the full abstract at the source